Primecap Management CO Fibrogen Inc Put Options Transaction History
Primecap Management CO
- $122 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
45Shares Held
18.9MCall Options Held
461KPut Options Held
102K-
Armistice Capital, LLC New York, NY8.5MShares$74 Million0.04% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$21 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.21MShares$19.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.37MShares$12 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny676KShares$5.89 Million0.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $816M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...